Introduction {#s1}
============

Inadequate gut absorptive surface area or defective gut motility may lead to total parental nutrition (TPN) dependence, termed intestinal failure (IF). Congenital anatomic abnormalities, necrotizing enterocolitis and severe motility defects account for most cases of IF \[[@R01]\]. Neonates with IF have prolonged admissions in the neonatal intensive care unit (NICU), have increased healthcare expenditures \[[@R02]\], and ultimately require lifelong follow-up with gastroenterology (GE) as outpatients. In most centers, NICU care of these patients is shared between NICU teams, surgeons, and GI consultants who rotate on and off service at least weekly, with variable interest and expertise in IF. Long-term decision making in this complex patient population is thus shared amongst short-term providers who may or may not have an investment in outpatient care, and who may not feel that they have the resources to discharge a patient on parenteral nutrition. In our own NICU, we noticed that this pattern was associated with highly variable discharge criteria and unnecessary increases in length of stay (LOS). Patients were often held to attempt to achieve arbitrary enteral feeding goals when it was clear from their post-operative anatomy that they would never achieve enteral autonomy in the first 6 - 12 months of life. Outpatient-based multidisciplinary care models for IF have been described and were associated with improved patient outcomes \[[@R03]\], but little is published on inpatient care programs or optimal discharge timing from the hospital. We aimed to assess the positive and negative impact of a simple intervention in the NICU to shorten LOS for IF patients.

Materials and Methods {#s2}
=====================

We undertook a quality improvement initiative to centralize care in NICU patients with IF and institute standardized discharge criteria. Two gastroenterologists who manage outpatients with IF, central lines and TPN were assigned to rotate weekly in our NICU. They performed all nonurgent consultations, family care conferences, and weekly inpatient follow-up. We implemented standardized, optimal discharge goals for patients with IF ([Table 1](#T1){ref-type="table"}) to better identify patients who could be safely cared for at home. All post-NICU outpatient care was performed by the same two gastroenterologists. After 18 months, we reviewed medical records of patients who met optimal discharge criteria and compared their outcomes to a historical cohort of IF patients. We assessed frequency of central line-associated bloodstream infection (CLABSI) as well as readmission to the hospital. This study was conducted in compliance with the ethical standards of the responsible institution on human subjects as well as with the Helsinki Declaration, and with institutional review board approval.

###### Optimal Discharge Timing Criteria for Neonates With Intestinal Failure

  -------------------------------------------------------------------------------------------
  A neonate can be considered for discharge and outpatient gastroenterology follow-up when:
    Continuous enteral feedings of at least 5 mL/h for 48 h are tolerated
    An indwelling central venous catheter appropriate for home use is in place
    Parenteral nutrition is cycled to at least 20 h/day or less and tolerated
    No other medical conditions requiring NICU care are present
  -------------------------------------------------------------------------------------------

Results {#s3}
=======

During the study period, optimal discharge criteria were met in 12 patients with IF (optimal group). Three patients with IF did not meet discharge criteria due to needs surrounding care of a tracheostomy, progressive liver disease, and lack of a safe home environment, respectively. A cohort of 26 historical patients was identified (historical group) for comparison. The etiology of IF in the optimal versus historical group was gastroschisis with bowel atresias in 75% vs. 53%, volvulus in 8% vs. 11%, necrotizing enterocolitis in 9% vs. 27%, and other in 8% vs. 9%, respectively (all P = NS). Patients in optimal and historical groups had similar baseline characteristics (medians, all P = NS): gestational age (36 vs. 35 weeks), birth weight (1,990 vs. 2,076 g), birth length (45 vs. 44 cm), and small bowel length after definitive surgery (63 vs. 55 cm), respectively ([Fig. 1](#F1){ref-type="fig"}). Compared with the historical group, the optimal group was discharged much earlier (median LOS 69 vs. 126 days, P \< 0.01) ([Fig. 2](#F2){ref-type="fig"}), experienced fewer CLABSIs (4 vs. 10 per 1,000 patient days, P = 0.04), and was readmitted less frequently (7 vs. 17 per 1,000 patient days, P \< 0.01). Both groups achieved enteral autonomy during the first year after discharge at similar rates: 5/12 (42%) in optimal and 8/26 (31%) in historical groups (P = NS). There were no deaths in 1 year of post-discharge follow-up in either group.
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Discussion {#s4}
==========

When management of IF in the NICU was restricted to a small team of gastroenterologists with an investment in outpatient care who instituted standardized discharge criteria, LOS decreased substantially without untoward safety events. This change in practice resulted in savings of 684 NICU days (57 days per patient), with fewer CLABSIs after discharge and fewer readmissions compared to historical management practices. At approximately 4,000 dollars per day in hospital charges to stay in a NICU, this program saved over 2.7 million dollars in care costs while allowing families and their infants more time at home. Providers established early relationships with families over multiple encounters prior to discharge, with repeated opportunities for education, anticipatory guidance and shared decision making. Many patients with IF can be managed safely at home, at substantial cost savings. The safety and applicability of the optimal discharge criteria presented here should be studied further. Similar programs may be effective at other large academic medical centers.
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